Trials / Completed
CompletedNCT01944215
Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.
Detailed description
The primary objective of this study is to determine if exercise, fasting, or eating prior to a molecular breast imaging study will have an effect on the uptake of the radiotracer Tc-99m sestamibi in the breast tissue. Tc-99m sestamibi is primarily extracted by the liver. Changes in hepatic blood flow may therefore influence the amount of radiotracer available for uptake in the breast tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Meal | effect of meal |
| OTHER | Exercise | effect of exercise |
| RADIATION | Sestamibi | reduce radiation dose |
| DRUG | Caffeine Tablet | effect of caffeine |
| OTHER | External Heating | Heating Pad and warm blanket robe |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2013-09-17
- Last updated
- 2017-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01944215. Inclusion in this directory is not an endorsement.